Gregory W. Mattingly, MD is an Associate Clinical Professor and Psychopharmacology Instructor at the Washington University School of Medicine in St. Louis and is also the President of the Midwest Research Group.
Dr. Mattingly earned his undergraduate degree in chemical engineering and completed his medical degree at the Washington University School of Medicine in St. Louis where he received a Fulbright Scholarship. Board certified in psychiatry with a subspecialty in adolescent psychiatry. Dr Mattingly serves on the board of directors for APSARD, the American Professional Society for ADHD and Related Disorders. Dr Mattingly has received numerous awards and distinctions including the Academy of Child and Adolescent Psychiatry National Leadership Award, the Upjohn Neuropsychiatry Research Award, and the Southern Psychiatric Association Research Award.
Dr. Mattingly has been a principal investigator in more than two hundred clinical trials, as well as an invited presenter at numerous medical conferences, both nationally and internationally. Dr. Mattingly’s work has been published in The Journal of Neuropsychiatry and Clinical Neurosciences., The Journal of Clinical Psychiatry, The Journal of the American Academy of Child and Adolescent Psychiatry, Current Psychiatry, CNS Spectrums and Postgraduate Medicine.
To contact GME, email us at [email protected]